Quotient Sciences Proprietary AI-Enhanced Solution Optimizes Formulation in Clinical Study

Quotient said its proprietary algorithm optimized tablet composition and dose level for a clinical study in healthy participants. Interim results indicate the approach could enable optimized drug formulations with fewer clinical-study rounds, potentially improving development efficiency. The announcement provides early validation but contains no disclosed clinical efficacy data or financial impact.